SCHEMBL1172901

SCHEMBL1172901

CC1(c2cccc(NC(=O)C3(C(F)(F)F)CC3)c2)COCC(N)=N1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.64
APP P05067 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1173838 0.83 BACE1 (0.65) BACE1APP
SCHEMBL2582229 0.78 BACE1 (0.66) BACE1APP
SCHEMBL6936794 0.78 BACE1 (0.62) BACE1APP
SCHEMBL363040 0.78 BACE1 (1.00) BACE1APP
SCHEMBL362993 0.78 BACE1 (1.00) BACE1APP
SCHEMBL360942 0.78 BACE1 (1.00) BACE1APP
SCHEMBL1910516 0.77 BACE1 (0.65) BACE1APP
SCHEMBL362824 0.77 BACE1 (1.00) BACE1APP
SCHEMBL361087 0.77 BACE1 (1.00) BACE1APP
SCHEMBL568075 0.77 BACE1 (0.61) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110046122-A1 3-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES SIENA BIOTECH S.P.A. (IT) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046122-A1 3-AMINO-5-PHENYL-5,6-DIHYDRO-2H-[1,4]OXAZINES BACE2, BACE1, APP BACE1 2/4885APP 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.